Versiti Acquires Solvita Blood Center (formerly Community Blood Center)

Versiti Acquires Quantigen

July 10, 2023

Healthcare Services

Versiti, a national blood health organization headquartered in Milwaukee, has acquired Quantigen, a specialty laboratory and contract research organization based in Fishers, Indiana. The acquisition expands Versiti’s clinical-trials and diagnostic capabilities—adding assay development, biomarker validation, and regulatory support for preclinical and clinical research.

BioIVT Acquires Tennessee Blood Services

April 4, 2022

Healthcare Services

BioIVT acquired Tennessee Blood Services (TBS), a commercial blood bank and donor center based in Memphis, Tennessee. The acquisition expands BioIVT’s donor network and increases its capacity and control over fresh whole blood, plasma, serum and red blood cell supplies for drug and diagnostic development; financial terms were not disclosed.

Versiti Acquires Pearl Pathways

November 7, 2023

Healthcare Services

Versiti, a Milwaukee-based blood health organization, has acquired Pearl Pathways, an Indianapolis-area life science consulting firm that provides regulatory affairs, quality compliance, CRO services and an independent IRB. The acquisition expands Versiti's clinical trial and life-sciences service capabilities, enabling earlier and deeper support for product development across biopharmaceutical, medical device, and diagnostics clients.

InVita Healthcare Technologies / The Riverside Company Acquire BloodHub

October 6, 2022

Cloud & SaaS

InVita Healthcare Technologies, a portfolio company of The Riverside Company, has acquired BloodHub and folded it into InVita's Blood Management Division. Riverside made the investment as an add-on to its InVita platform to expand InVita's blood- and biologics-focused supply chain and laboratory software capabilities across North America.

Versiti Acquires Ethical and Independent Review Services (E&I)

July 12, 2022

Healthcare Services

Versiti, a national blood health organization headquartered in Milwaukee, has acquired Missouri-based Ethical and Independent Review Services (E&I), an AAHRPP-accredited independent IRB. The acquisition expands Versiti's clinical trial services and regulatory review capabilities across biopharmaceutical, medical device, and social/behavioral research markets.

BioIVT Acquires BeCytes Biotechnologies

November 4, 2025

Biotechnology

BioIVT has acquired BeCytes Biotechnologies, a Barcelona-based provider of ethically sourced human tissues and primary cell isolation services. The deal expands BioIVT's European footprint and strengthens its capabilities for New Approach Methodologies (NAMs) and ADME research; BeCytes will continue to operate from Barcelona and financial terms were not disclosed.